Nuclear Radiology: Page 7

United Imaging highlights new PET/CT scanner at EANM 2022

By AuntMinnieEurope.com staff writers

United Imaging Healthcare showcased its PET/CT device, uExplorer, at the European Association of Nuclear Medicine (EANM) annual congress in Barcelona.

October 24, 2022

Shine secures Dutch approval for terbium isotope development grant

By AuntMinnieEurope.com staff writers

Shine Technologies has secured approval from the Dutch government for a grant proposal to develop terbium isotopes for nuclear medicine imaging.

October 20, 2022

ITM to boost Lu-177 production

By AuntMinnieEurope.com staff writers

ITM Isotope Technologies Munich completed work on a new production line for non-carrier-added lutetium-177 (Lu-177) at its manufacturing facility in Garching, Germany.

October 16, 2022

Telix highlights EANM presentations

By AuntMinnieEurope.com staff writers

Telix Pharmaceuticals is highlighting presentations on the company's theranostics radiopharmaceuticals that will take place at the European Association of Nuclear Medicine (EANM) 2022 Congress, in Barcelona, Spain, from 15-19 October.

October 10, 2022

SPECT tracer shows promise in diagnosis of prostate cancer

By Will Morton

More metastatic bone tumors can be diagnosed in patients with prostate cancer using SPECT/CT with an experimental radiotracer compared with conventional methods, a new global study has found.

October 4, 2022

Monrol plans to open radiopharmaceutical facility in Germany

By AuntMinnieEurope.com staff writers

Istanbul-based Eczacibasi-Monrol Nuclear Products (Monrol) said it plans to open a facility in Germany to produce radiopharmaceuticals for imaging and radioligand therapy.

September 29, 2022

Global radiation issues generate discussion in Vienna

By Will Morton

Improving radiation medicine capabilities in poorer countries is essential to bridge the substantial worldwide differences in cancer care, delegates agreed at this week's International Atomic Energy Agency's 2022 Scientific Forum in Vienna.

September 29, 2022

GE, Lantheus highlight flurpiridaz trial results

By AuntMinnieEurope.com staff writers

A phase III trial found that Lantheus Medical Imaging's flurpiridaz F-18 investigational PET radiopharmaceutical outperformed SPECT myocardial perfusion imaging in patients with suspected coronary artery disease.

September 13, 2022

How widespread is fraud in nuclear medicine research?

By Will Morton

Leading Dutch researchers claim that fraud may be a problem in nuclear medicine journals, based on the results of their global survey. Their findings were published on 8 September in the Journal of Nuclear Medicine.

September 12, 2022

First patient in Oncoinvent trial treated for colorectal cancer

By AuntMinnieEurope.com staff writers

Norwegian radiopharmaceutical developer Oncoinvent is highlighting that the first colorectal cancer patient has been treated in a clinical trial of the company's Radspherin drug candidate.

August 25, 2022

U.K. clears Lu-177 PSMA-617 treatment for prostate cancer

By AuntMinnieEurope.com staff writers

The U.K. regulators have become the first in Europe to clear lutetium-177 (Lu-177) prostate-specific membrane antigen (PSMA)-617 treatment for prostate cancer, drug developer Novartis has announced in a news release issued on 11 August.

August 14, 2022

Russia invests in nuclear medicine research facility in Bolivia

By Will Morton

Bolivia has opened a nuclear research center in La Paz -- more than 4000 m above sea level. The $300 million facility is the world's highest-altitude site producing medical radioisotopes, and is a joint effort between the Bolivian Nuclear Energy Agency and the Russian giant Rosatom.

August 14, 2022

Previous Page

Page 7 of 90

Next Page